Back
Mersana Therapeutics 10K Form
Sell
18
MRSN
Mersana Therapeutics
Last Price:
2.57
Seasonality Move:
-4.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-07 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2020-05-08 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2020-02-28 | 10K | MRSN/Mersana Therapeutics Annual |
| 2019-11-06 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2019-08-08 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2019-05-09 | 10Q | MRSN/Mersana Therapeutics Quarterly |
Receive MRSN News And Ratings
See the #1 stock for the next 7 days that we like better than MRSN
MRSN Financial Statistics
Sales & Book Value
| Annual Sales: | $36.86M |
|---|---|
| Cash Flow: | $-32.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.23 |
| Price / Book: | 11.41 |
Profitability
| EPS (TTM): | -1.14000 |
|---|---|
| Net Income (TTM): | $-134.81M |
| Gross Margin: | -- |
| Return on Equity: | -248.57% |
| Return on Assets: | -52.07% |
Mersana Therapeutics Earnings Forecast
Key Mersana Therapeutics Financial Ratios
- The Research & Development expenses have been 402.30% of Revenue.
- The Interest Expense is -2.37% of Operating Income.
- The Net Earning history of MRSN is -465.80% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Mersana Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRSN |
| CUSIP: | 59045L |
| Website: | mersana.com |
Debt
| Debt-to-Equity Ratio: | 0.9 |
|---|---|
| Current Ratio: | 3.51 |
| Quick Ratio: | 3.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MRSN Technical Analysis vs Fundamental Analysis
Sell
18
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a Sell
The current Mersana Therapeutics [MRSN] share price is $2.61. The Score for MRSN is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.